Dihydrofolate Reductase Inhibitor Antibacterial [EPC]

Dihydrofolate Reductase Inhibitor Antibacterial [EPC] was reported 96269 times

Drugs of the Dihydrofolate Reductase Inhibitor Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VAGINAL FLATULENCE 182 0.6007
1 PULMONARY VASCULITIS 130 0.2416
2 C-REACTIVE PROTEIN 191 0.2060
3 TOTAL LUNG CAPACITY ABNORMAL 80 0.2057
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 380 0.1897
5 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 101 0.1800
6 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1094 0.1683
7 MUSCLE INJURY 1297 0.1564
8 DUODENAL ULCER PERFORATION 1133 0.1522
9 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 314 0.1514
10 X-RAY ABNORMAL 269 0.1503
11 SWOLLEN JOINT COUNT INCREASED 471 0.1476
12 FOLLICULITIS 1516 0.1444
13 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 94 0.1407
14 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 101 0.1378
15 FACET JOINT SYNDROME 444 0.1362
16 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 972 0.1355
17 SPIROMETRY ABNORMAL 80 0.1338
18 MITE ALLERGY 86 0.1313
19 RHEUMATIC FEVER 564 0.1264
20 DISLOCATION OF VERTEBRA 278 0.1218
21 FEMALE GENITAL TRACT FISTULA 208 0.1217
22 LUPUS VULGARIS 150 0.1190
23 FEBRILE BONE MARROW APLASIA 506 0.1189
24 MYCOTIC ALLERGY 96 0.1123
25 HELICOBACTER INFECTION 1137 0.1105
26 SOFT TISSUE DISORDER 122 0.1100
27 IMMUNE RECONSTITUTION SYNDROME 131 0.1015
28 RHEUMATOID FACTOR POSITIVE 572 0.0989
29 HYPOFIBRINOGENAEMIA 94 0.0948
30 HAND DEFORMITY 1185 0.0903
31 NEURITIS 134 0.0867
32 C-REACTIVE PROTEIN ABNORMAL 553 0.0861
33 PEMPHIGUS 1064 0.0850
34 RADICULOPATHY 218 0.0826
35 APLASIA 156 0.0796
36 BLOOD PRESSURE DIASTOLIC ABNORMAL 200 0.0786
37 DUST ALLERGY 77 0.0785
38 PORPHYRIA ACUTE 107 0.0746
39 PROCTITIS 208 0.0742
40 SYNOVITIS 1284 0.0711
41 RETINITIS 122 0.0706
42 PERIPHERAL VENOUS DISEASE 287 0.0702
43 IRRITABLE BOWEL SYNDROME 1479 0.0689
44 PERICARDITIS 1113 0.0662
45 ENCEPHALITIS VIRAL 80 0.0657
46 BLOOD PRESSURE SYSTOLIC ABNORMAL 157 0.0635
47 CHRONIC SINUSITIS 235 0.0625
48 GRANULOMATOSIS WITH POLYANGIITIS 73 0.0605
49 PNEUMOCYSTIS JIROVECI PNEUMONIA 131 0.0587
50 MIXED LIVER INJURY 172 0.0571
51 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 115 0.0563
52 LIP DRY 511 0.0562
53 MATERNAL EXPOSURE TIMING UNSPECIFIED 211 0.0561
54 AGRANULOCYTOSIS 1038 0.0558
55 GLOSSODYNIA 1233 0.0550
56 CONJUNCTIVITIS ALLERGIC 81 0.0547
57 PARAINFLUENZAE VIRUS INFECTION 81 0.0532
58 RESPIRATORY SYMPTOM 145 0.0509
59 SCLERITIS 81 0.0505
60 RASH MACULO-PAPULAR 1106 0.0497
61 JOINT RANGE OF MOTION DECREASED 664 0.0495
62 IMPAIRED HEALING 1625 0.0494
63 FORCED EXPIRATORY VOLUME DECREASED 140 0.0494
64 KIDNEY TRANSPLANT REJECTION 227 0.0473
65 RASH MORBILLIFORM 131 0.0472
66 BICYTOPENIA 92 0.0469
67 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1201 0.0466
68 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 152 0.0460
69 WOUND 1283 0.0459
70 DERMATITIS EXFOLIATIVE GENERALISED 155 0.0445
71 HEPATIC CYTOLYSIS 568 0.0445
72 RENAL TUBULAR DISORDER 124 0.0440
73 TOXIC SKIN ERUPTION 440 0.0436
74 CYTOLYTIC HEPATITIS 145 0.0436
75 HISTIOCYTOSIS HAEMATOPHAGIC 129 0.0434
76 HUMAN HERPESVIRUS 6 INFECTION 81 0.0428
77 HEPATOCELLULAR INJURY 605 0.0426
78 PNEUMONIA VIRAL 136 0.0426
79 BURSITIS 509 0.0419
80 WOUND INFECTION 452 0.0412
81 RENAL TUBULAR ACIDOSIS 90 0.0412
82 AUTOIMMUNE DISORDER 401 0.0411
83 COMPLICATIONS OF TRANSPLANTED KIDNEY 93 0.0410
84 CREPITATIONS 121 0.0406
85 BREAST CANCER STAGE III 261 0.0403
86 NORMOCHROMIC NORMOCYTIC ANAEMIA 120 0.0399
87 NOCARDIOSIS 102 0.0398
88 BONE EROSION 140 0.0395
89 CHOLESTASIS 760 0.0395
90 LIVER TRANSPLANT REJECTION 71 0.0395
91 CYTOMEGALOVIRUS TEST POSITIVE 70 0.0392
92 RHINOVIRUS INFECTION 152 0.0390
93 TRANSPLANT REJECTION 312 0.0389
94 LOWER RESPIRATORY TRACT INFECTION 1763 0.0387
95 PLEURITIC PAIN 106 0.0384
96 PULMONARY ALVEOLAR HAEMORRHAGE 215 0.0383
97 GRAFT VERSUS HOST DISEASE 275 0.0382
98 CYTOKINE RELEASE SYNDROME 762 0.0379
99 HYPERKALAEMIA 1332 0.0379
100 HYPERCHOLESTEROLAEMIA 363 0.0376
101 CYTOMEGALOVIRUS INFECTION 619 0.0372
102 ANAEMIA MACROCYTIC 79 0.0370
103 GRAFT VERSUS HOST DISEASE IN SKIN 81 0.0367
104 HYPERPARATHYROIDISM SECONDARY 91 0.0363
105 MACULAR DEGENERATION 433 0.0362
106 FIBROMYALGIA 880 0.0362
107 CHOLESTATIC LIVER INJURY 80 0.0359
108 GRIP STRENGTH DECREASED 316 0.0359
109 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 83 0.0357
110 APLASTIC ANAEMIA 186 0.0356
111 ESCHERICHIA URINARY TRACT INFECTION 151 0.0355
112 BRONCHOPULMONARY ASPERGILLOSIS 274 0.0353
113 SYSTEMIC LUPUS ERYTHEMATOSUS 1247 0.0351
114 CUSHINGOID 111 0.0345
115 ESCHERICHIA BACTERAEMIA 81 0.0344
116 LYMPHOPENIA 482 0.0340
117 EOSINOPHILIA 592 0.0337
118 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 108 0.0332
119 TOXIC EPIDERMAL NECROLYSIS 505 0.0332
120 NEPHROGENIC ANAEMIA 154 0.0332
121 ORAL CANDIDIASIS 436 0.0331
122 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 85 0.0329
123 PNEUMOCYSTIS JIROVECII PNEUMONIA 330 0.0328
124 CYTOMEGALOVIRUS VIRAEMIA 146 0.0328
125 ESCHERICHIA SEPSIS 95 0.0327
126 FEBRILE NEUTROPENIA 2173 0.0327
127 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 178 0.0327
128 BACTERIAL SEPSIS 106 0.0325
129 PANCYTOPENIA 1813 0.0324
130 STOMATITIS 1953 0.0322
131 NEUROLOGICAL SYMPTOM 183 0.0320
132 PULMONARY FIBROSIS 614 0.0320
133 PSEUDOMONAS INFECTION 273 0.0318
134 PUSTULAR PSORIASIS 109 0.0317
135 BK VIRUS INFECTION 105 0.0311
136 STEVENS-JOHNSON SYNDROME 686 0.0308
137 SCIATICA 481 0.0301
138 BLISTER 1683 0.0299
139 CONTRAINDICATED PRODUCT ADMINISTERED 903 0.0298
140 THROMBOTIC MICROANGIOPATHY 288 0.0295
141 HEPATITIS CHOLESTATIC 178 0.0295
142 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 112 0.0293
143 RALES 169 0.0291
144 HYPERTRIGLYCERIDAEMIA 170 0.0290
145 APLASIA PURE RED CELL 99 0.0287
146 SYSTEMIC CANDIDA 72 0.0287
147 PNEUMONIA FUNGAL 113 0.0286
148 DERMATITIS EXFOLIATIVE 141 0.0281
149 RASH VESICULAR 136 0.0281
150 CLOSTRIDIUM DIFFICILE COLITIS 297 0.0280
151 LIVE BIRTH 232 0.0277
152 ENTEROCOCCAL INFECTION 134 0.0277
153 CHRONIC GRAFT VERSUS HOST DISEASE 99 0.0274
154 POTENTIATING DRUG INTERACTION 92 0.0274
155 BLOOD CULTURE POSITIVE 82 0.0274
156 HEPATITIS FULMINANT 81 0.0273
157 INFUSION RELATED REACTION 1807 0.0272
158 MYOSITIS 244 0.0272
159 WALKING AID USER 178 0.0270
160 RENAL TUBULAR NECROSIS 263 0.0268
161 REBOUND ACID HYPERSECRETION 81 0.0268
162 THERAPEUTIC PRODUCT EFFECT DECREASED 1188 0.0265
163 RHEUMATOID NODULE 73 0.0265
164 HYPERLACTACIDAEMIA 71 0.0265
165 TENOSYNOVITIS 73 0.0264
166 RENAL FAILURE ACUTE 1114 0.0262
167 SERUM SICKNESS 73 0.0262
168 DRUG TOLERANCE DECREASED 73 0.0260
169 ATELECTASIS 250 0.0258
170 LUNG CONSOLIDATION 72 0.0257
171 OESOPHAGEAL CANDIDIASIS 102 0.0256
172 ECONOMIC PROBLEM 386 0.0254
173 LIVER INJURY 625 0.0254
174 TUMOUR LYSIS SYNDROME 224 0.0254
175 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 70 0.0253
176 STAPHYLOCOCCAL SEPSIS 124 0.0251
177 CHRONIC LYMPHOCYTIC LEUKAEMIA 119 0.0251
178 ONYCHOMADESIS 104 0.0248
179 MENINGITIS ASEPTIC 111 0.0247
180 LUNG DISORDER 1208 0.0246
181 NIGHT SWEATS 794 0.0246
182 KLEBSIELLA INFECTION 124 0.0245
183 SQUAMOUS CELL CARCINOMA OF SKIN 148 0.0245
184 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 145 0.0245
185 HAEMOLYTIC ANAEMIA 219 0.0244
186 LOWER LIMB FRACTURE 469 0.0244
187 HYPERTHERMIA 186 0.0243
188 VASCULITIS 283 0.0243
189 HYPERURICAEMIA 99 0.0241
190 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 119 0.0239
191 OBESITY 379 0.0238
192 HYPOGAMMAGLOBULINAEMIA 156 0.0237
193 ARTHROPATHY 1319 0.0237
194 LEUKOPENIA 1183 0.0236
195 RENAL TRANSPLANT 85 0.0235
196 SEPTIC SHOCK 1023 0.0235
197 BONE MARROW FAILURE 474 0.0233
198 PURPURA 205 0.0231
199 SINUSITIS 2374 0.0231
200 ILL-DEFINED DISORDER 1407 0.0231
201 THROMBOCYTOPENIA 2567 0.0229
202 EAR PAIN 445 0.0229
203 TYPE 2 DIABETES MELLITUS 769 0.0228
204 BODY TEMPERATURE INCREASED 466 0.0228
205 ACUTE KIDNEY INJURY 3491 0.0228
206 ARTERIOSCLEROSIS CORONARY ARTERY 151 0.0228
207 HEPATIC ENZYME INCREASED 1540 0.0226
208 BACTERAEMIA 266 0.0224
209 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 173 0.0222
210 ANTINUCLEAR ANTIBODY POSITIVE 72 0.0221
211 ONYCHOMYCOSIS 97 0.0221
212 CYSTITIS HAEMORRHAGIC 89 0.0221
213 FULL BLOOD COUNT ABNORMAL 232 0.0219
214 END STAGE RENAL DISEASE 400 0.0219
215 MUSCLE SPASTICITY 268 0.0218
216 CANDIDIASIS 87 0.0217
217 VAGINAL DISCHARGE 219 0.0216
218 ACUTE GRAFT VERSUS HOST DISEASE 99 0.0216
219 TENDERNESS 224 0.0215
220 MUCOSAL INFLAMMATION 562 0.0214
221 STAPHYLOCOCCAL BACTERAEMIA 93 0.0214
222 BREAST CANCER STAGE II 177 0.0213
223 NEUTROPENIA 2891 0.0212
224 ASPERGILLUS INFECTION 139 0.0212
225 PYELONEPHRITIS 183 0.0211
226 LUNG INFILTRATION 186 0.0210
227 HYPERBILIRUBINAEMIA 218 0.0210
228 INFECTION 2978 0.0206
229 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 154 0.0205
230 GASTROINTESTINAL DISORDER 1829 0.0204
231 SWELLING 1908 0.0204
232 MULTIPLE MYELOMA 95 0.0204
233 DIFFUSE LARGE B-CELL LYMPHOMA 157 0.0204
234 CYTOMEGALOVIRUS INFECTION REACTIVATION 90 0.0204
235 OBSTRUCTIVE AIRWAYS DISORDER 226 0.0203
236 WHEEZING 1203 0.0203
237 HEPATITIS 519 0.0203
238 PYREXIA 6981 0.0202
239 HEPATITIS ACUTE 131 0.0201
240 SYNOVIAL CYST 93 0.0201
241 LIVER TRANSPLANT 73 0.0201
242 VASCULAR DEVICE INFECTION 91 0.0200
243 BONE LESION 72 0.0199
244 HYPOALBUMINAEMIA 155 0.0199
245 SERUM FERRITIN INCREASED 105 0.0199
246 EXOSTOSIS 181 0.0198
247 ACUTE PULMONARY OEDEMA 111 0.0198
248 HYPOVOLAEMIA 115 0.0196
249 DISCOMFORT 1197 0.0196
250 HYPONATRAEMIA 1099 0.0195
251 C-REACTIVE PROTEIN INCREASED 704 0.0193
252 NEUTROPENIC SEPSIS 138 0.0193
253 ORTHOSTATIC HYPOTENSION 335 0.0192
254 ACUTE RESPIRATORY DISTRESS SYNDROME 340 0.0192
255 HYPOPHOSPHATAEMIA 142 0.0192
256 UROSEPSIS 177 0.0192
257 HYPOXIA 671 0.0190
258 JOINT EFFUSION 131 0.0190
259 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 194 0.0189
260 CYTOPENIA 231 0.0188
261 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 155 0.0188
262 CYSTIC FIBROSIS 104 0.0188
263 BLOOD CREATININE INCREASED 1218 0.0186
264 LIVER DISORDER 824 0.0186
265 FLANK PAIN 174 0.0185
266 OEDEMA 1006 0.0185
267 JOINT SWELLING 2235 0.0185
268 LEFT VENTRICULAR DYSFUNCTION 124 0.0185
269 PROCTALGIA 119 0.0185
270 GAIT INABILITY 618 0.0185
271 PERIPHERAL SENSORY NEUROPATHY 107 0.0183
272 DERMATITIS BULLOUS 132 0.0182
273 PARAESTHESIA ORAL 261 0.0181
274 NODULE 235 0.0180
275 ANHEDONIA 472 0.0179
276 TUBULOINTERSTITIAL NEPHRITIS 336 0.0179
277 LIPASE INCREASED 137 0.0179
278 NAIL DISORDER 156 0.0178
279 CONTUSION 1715 0.0178
280 BLOOD LACTATE DEHYDROGENASE INCREASED 282 0.0178
281 RESPIRATORY DISORDER 530 0.0177
282 CACHEXIA 91 0.0177
283 PETECHIAE 184 0.0176
284 COVID-19 PNEUMONIA 208 0.0176
285 PHLEBITIS 90 0.0176
286 BLOOD LACTIC ACID INCREASED 92 0.0174
287 HEPATOMEGALY 171 0.0174
288 CANDIDA INFECTION 291 0.0172
289 CONFUSIONAL STATE 2783 0.0172
290 BRONCHIECTASIS 116 0.0172
291 PRESCRIBED OVERDOSE 333 0.0172
292 ESCHERICHIA INFECTION 141 0.0171
293 PNEUMONIA BACTERIAL 157 0.0171
294 BLOOD UREA INCREASED 285 0.0170
295 BLOOD PRESSURE SYSTOLIC INCREASED 330 0.0169
296 CLOSTRIDIUM DIFFICILE INFECTION 369 0.0169
297 BLOOD CHOLESTEROL INCREASED 787 0.0169
298 ENCEPHALOPATHY 413 0.0168
299 FACE OEDEMA 283 0.0168
300 FAILURE TO THRIVE 87 0.0167
301 DRUG INTOLERANCE 1611 0.0167
302 BENIGN PROSTATIC HYPERPLASIA 86 0.0166
303 GAMMA-GLUTAMYLTRANSFERASE INCREASED 367 0.0165
304 STAPHYLOCOCCAL INFECTION 546 0.0165
305 IMMUNOSUPPRESSION 146 0.0165
306 ORGANISING PNEUMONIA 82 0.0165
307 HIP ARTHROPLASTY 252 0.0164
308 PREGNANCY 329 0.0164
309 HYDRONEPHROSIS 123 0.0164
310 BLOOD ALKALINE PHOSPHATASE INCREASED 408 0.0164
311 OSTEOPENIA 249 0.0164
312 ARTHRITIS INFECTIVE 76 0.0164
313 OSTEOARTHRITIS 693 0.0163
314 FINGER DEFORMITY 79 0.0163
315 HYPOVOLAEMIC SHOCK 78 0.0163
316 MALNUTRITION 182 0.0163
317 PLASMA CELL MYELOMA 632 0.0162
318 MULTI-ORGAN FAILURE 280 0.0162
319 INJURY 1138 0.0162
320 LYMPHOCYTE COUNT DECREASED 286 0.0162
321 NEUTROPHIL COUNT DECREASED 659 0.0162
322 BACTERIAL INFECTION 301 0.0161
323 BLOOD CREATINE INCREASED 71 0.0160
324 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 153 0.0160
325 CHRONIC KIDNEY DISEASE 1216 0.0160
326 EPSTEIN-BARR VIRUS INFECTION 99 0.0158
327 CONJUNCTIVITIS 292 0.0157
328 RENAL FAILURE CHRONIC 121 0.0157
329 ARTERIOSCLEROSIS 148 0.0157
330 ANAEMIA 2997 0.0157
331 EAR INFECTION 418 0.0157
332 ACUTE RESPIRATORY FAILURE 302 0.0157
333 HERPES SIMPLEX 102 0.0157
334 LUPUS-LIKE SYNDROME 142 0.0156
335 PSORIATIC ARTHROPATHY 635 0.0156
336 PERIPHERAL SWELLING 2409 0.0156
337 BLOOD ALBUMIN DECREASED 124 0.0156
338 ECCHYMOSIS 107 0.0156
339 HYPERCALCAEMIA 191 0.0155
340 PRESCRIBED UNDERDOSE 308 0.0154
341 RESPIRATORY RATE INCREASED 137 0.0154
342 INFLAMMATION 796 0.0154
343 BLEPHAROSPASM 97 0.0154
344 DELIRIUM 534 0.0154
345 PATHOLOGICAL FRACTURE 78 0.0154
346 SEPSIS 1713 0.0153
347 ROAD TRAFFIC ACCIDENT 641 0.0153
348 INTERSTITIAL LUNG DISEASE 739 0.0152
349 SINUS TACHYCARDIA 216 0.0152
350 HYPERVOLAEMIA 75 0.0152
351 LIVER FUNCTION TEST ABNORMAL 440 0.0151
352 PANCREATITIS ACUTE 339 0.0151
353 SWOLLEN TONGUE 471 0.0151
354 ODYNOPHAGIA 90 0.0151
355 SPINAL OSTEOARTHRITIS 132 0.0150
356 RHINITIS 121 0.0150
357 CHEILITIS 81 0.0150
358 PATHOGEN RESISTANCE 136 0.0149
359 SPLENOMEGALY 174 0.0148
360 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 252 0.0148
361 MUSCULOSKELETAL PAIN 774 0.0148
362 HEPATITIS B 89 0.0148
363 BLOOD PRESSURE DIASTOLIC DECREASED 109 0.0148
364 SLEEP DISORDER 1041 0.0147
365 COLITIS 558 0.0147
366 TRANSAMINASES INCREASED 327 0.0147
367 RENAL FAILURE 1949 0.0147
368 HAEMATOCRIT DECREASED 291 0.0147
369 PNEUMONITIS 398 0.0146
370 VENOOCCLUSIVE LIVER DISEASE 72 0.0146
371 HAEMATURIA 498 0.0145
372 DEVICE RELATED INFECTION 223 0.0145
373 ENCEPHALITIS 100 0.0144
374 CHOLECYSTITIS CHRONIC 96 0.0143
375 HYPERNATRAEMIA 71 0.0142
376 HYPERLIPIDAEMIA 170 0.0142
377 ORAL PAIN 318 0.0142
378 PHARYNGITIS 176 0.0142
379 URINE OUTPUT DECREASED 124 0.0142
380 LUNG INFECTION 220 0.0141
381 RESPIRATORY DISTRESS 390 0.0141
382 BLOOD BILIRUBIN INCREASED 381 0.0141
383 HYPERSENSITIVITY 2616 0.0141
384 MYELODYSPLASTIC SYNDROME 203 0.0140
385 INTERNATIONAL NORMALISED RATIO INCREASED 400 0.0140
386 URINARY TRACT INFECTION 2388 0.0140
387 FREQUENT BOWEL MOVEMENTS 376 0.0139
388 SQUAMOUS CELL CARCINOMA 131 0.0139
389 JOINT DISLOCATION 147 0.0139
390 GENERAL PHYSICAL HEALTH DETERIORATION 1604 0.0138
391 TACHYPNOEA 188 0.0138
392 ATRIAL FLUTTER 110 0.0138
393 CELLULITIS 694 0.0138
394 SHOCK HAEMORRHAGIC 112 0.0137
395 NEPHROPATHY 128 0.0137
396 ELECTROLYTE IMBALANCE 159 0.0137
397 JAUNDICE 368 0.0137
398 FOOT DEFORMITY 151 0.0136
399 EJECTION FRACTION DECREASED 211 0.0136
400 ALANINE AMINOTRANSFERASE INCREASED 831 0.0135
401 ERYTHEMA MULTIFORME 126 0.0135
402 PNEUMOTHORAX 214 0.0135
403 ACIDOSIS 103 0.0135
404 FULL BLOOD COUNT DECREASED 271 0.0134
405 RESPIRATORY SYNCYTIAL VIRUS INFECTION 117 0.0134
406 COMPRESSION FRACTURE 72 0.0134
407 RECTAL HAEMORRHAGE 576 0.0134
408 ASPARTATE AMINOTRANSFERASE INCREASED 711 0.0134
409 HAEMOPTYSIS 373 0.0134
410 PLATELET COUNT DECREASED 1425 0.0134
411 HAEMODIALYSIS 112 0.0133
412 GASTROENTERITIS 194 0.0133
413 PULMONARY TOXICITY 94 0.0133
414 INFUSION SITE SWELLING 83 0.0132
415 GENERALISED ERYTHEMA 75 0.0132
416 BLOOD POTASSIUM INCREASED 214 0.0132
417 MULTIPLE ORGAN DYSFUNCTION SYNDROME 373 0.0132
418 METABOLIC ACIDOSIS 421 0.0132
419 CYSTITIS 419 0.0131
420 PHOTOPHOBIA 247 0.0131
421 RED BLOOD CELL SEDIMENTATION RATE INCREASED 145 0.0131
422 RESPIRATORY TRACT INFECTION 340 0.0130
423 MENTAL STATUS CHANGES 362 0.0130
424 NEUTROPHIL COUNT INCREASED 133 0.0130
425 DECREASED ACTIVITY 140 0.0130
426 PHOTOSENSITIVITY REACTION 213 0.0129
427 RHEUMATOID ARTHRITIS 1461 0.0129
428 PLEURAL EFFUSION 783 0.0129
429 BLOOD MAGNESIUM DECREASED 111 0.0128
430 RESPIRATORY FAILURE 933 0.0128
431 DECUBITUS ULCER 104 0.0127
432 STREPTOCOCCAL INFECTION 71 0.0127
433 HYPOKALAEMIA 588 0.0127
434 UPPER RESPIRATORY TRACT INFECTION 587 0.0127
435 PNEUMONIA ASPIRATION 317 0.0127
436 PROTHROMBIN TIME PROLONGED 75 0.0125
437 PROTEINURIA 238 0.0125
438 HYPOPHAGIA 320 0.0125
439 MYOCLONUS 149 0.0125
440 LEUKOCYTOSIS 226 0.0125
441 WHITE BLOOD CELL COUNT DECREASED 1350 0.0124
442 HEPATIC CIRRHOSIS 234 0.0124
443 DRUG-INDUCED LIVER INJURY 390 0.0124
444 OSTEOPOROSIS 511 0.0124
445 RED BLOOD CELL COUNT DECREASED 355 0.0124
446 GENERAL SYMPTOM 93 0.0124
447 NEPHROTIC SYNDROME 85 0.0124
448 HYPERTRANSAMINASAEMIA 86 0.0124
449 NEUROPATHY PERIPHERAL 1176 0.0124
450 ENTERITIS 79 0.0123
451 DYSPNOEA EXERTIONAL 464 0.0123
452 BLOOD SODIUM DECREASED 232 0.0123
453 OXYGEN SATURATION DECREASED 687 0.0122
454 PRODUCTIVE COUGH 582 0.0122
455 MUSCULOSKELETAL CHEST PAIN 188 0.0121
456 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 208 0.0121
457 BODY TEMPERATURE DECREASED 119 0.0121
458 RENAL CYST 96 0.0121
459 SWELLING FACE 787 0.0121
460 HAEMORRHOIDS 235 0.0120
461 DRUG LEVEL INCREASED 199 0.0120
462 CARDIAC MURMUR 104 0.0120
463 PULMONARY HAEMORRHAGE 94 0.0120
464 INTENTIONAL PRODUCT USE ISSUE 1052 0.0120
465 DISSEMINATED INTRAVASCULAR COAGULATION 169 0.0120
466 BACK DISORDER 195 0.0120
467 MENINGITIS 80 0.0120
468 PNEUMONIA 3873 0.0120
469 CHOLANGITIS 74 0.0119
470 RASH GENERALISED 309 0.0119
471 HAEMOGLOBIN DECREASED 1225 0.0119
472 INTERVERTEBRAL DISC DEGENERATION 110 0.0119
473 LYMPHADENOPATHY 420 0.0119
474 HYPOMAGNESAEMIA 165 0.0118
475 MOBILITY DECREASED 849 0.0118
476 RENAL IMPAIRMENT 989 0.0118
477 NEPHROPATHY TOXIC 132 0.0117
478 SPINAL COMPRESSION FRACTURE 97 0.0117
479 WHITE BLOOD CELL COUNT INCREASED 449 0.0117
480 ANGIOEDEMA 517 0.0117
481 RASH 5089 0.0117
482 KNEE ARTHROPLASTY 245 0.0116
483 VIRAL INFECTION 387 0.0116
484 OESOPHAGITIS 127 0.0116
485 DEEP VEIN THROMBOSIS 755 0.0116
486 MYOPATHY 100 0.0116
487 MUSCULOSKELETAL STIFFNESS 1014 0.0116
488 DRUG ERUPTION 205 0.0116
489 LIVER FUNCTION TEST INCREASED 248 0.0115
490 ACUTE MYELOID LEUKAEMIA 180 0.0115
491 NASOPHARYNGITIS 2125 0.0115
492 HEPATIC STEATOSIS 214 0.0115
493 ATAXIA 136 0.0114
494 OLIGURIA 71 0.0114
495 FUNGAL INFECTION 381 0.0114
496 COAGULOPATHY 190 0.0114
497 OEDEMA PERIPHERAL 1385 0.0114
498 ACUTE CORONARY SYNDROME 94 0.0113
499 DRY MOUTH 918 0.0113
500 GASTROINTESTINAL PAIN 124 0.0113
501 URTICARIA 1876 0.0112
502 NEUROTOXICITY 196 0.0112
503 REFUSAL OF TREATMENT BY PATIENT 73 0.0112
504 INFUSION SITE ERYTHEMA 94 0.0111
505 DRUG INTERACTION 1766 0.0111
506 GASTROOESOPHAGEAL REFLUX DISEASE 895 0.0111
507 NEURALGIA 270 0.0111
508 MITRAL VALVE INCOMPETENCE 124 0.0109
509 BONE DENSITY DECREASED 343 0.0109
510 BACK INJURY 119 0.0109
511 PULMONARY EMBOLISM 1039 0.0109
512 MOUTH ULCERATION 230 0.0109
513 ANOREXIA 140 0.0109
514 PULMONARY MASS 161 0.0108
515 TOOTH ABSCESS 110 0.0108
516 HEPATIC FAILURE 325 0.0108
517 PERICARDIAL EFFUSION 248 0.0107
518 DRUG RESISTANCE 275 0.0107
519 ANURIA 92 0.0107
520 GENERALISED OEDEMA 132 0.0107
521 ORAL DISORDER 78 0.0106
522 MATERNAL EXPOSURE DURING PREGNANCY 948 0.0106
523 ULCER 169 0.0106
524 ABDOMINAL PAIN 2471 0.0106
525 ABDOMINAL DISCOMFORT 1780 0.0106
526 SKIN INFECTION 119 0.0106
527 BLOOD PRESSURE FLUCTUATION 254 0.0106
528 HIATUS HERNIA 137 0.0106
529 RASH PUSTULAR 77 0.0106
530 DERMATITIS ALLERGIC 133 0.0106
531 DEHYDRATION 1409 0.0106
532 UPPER-AIRWAY COUGH SYNDROME 87 0.0105
533 SKIN LESION 289 0.0105
534 WEIGHT FLUCTUATION 110 0.0105
535 EMBOLISM 87 0.0105
536 VITAMIN D DEFICIENCY 102 0.0104
537 SEASONAL ALLERGY 148 0.0104
538 BLOOD CALCIUM DECREASED 117 0.0104
539 OSTEOMYELITIS 187 0.0103
540 CARDIOMEGALY 127 0.0103
541 RASH PRURITIC 558 0.0103
542 DYSURIA 377 0.0102
543 HAEMOLYSIS 79 0.0102
544 THERAPY NON-RESPONDER 459 0.0102
545 ASCITES 300 0.0102
546 APHTHOUS ULCER 79 0.0102
547 WEIGHT INCREASED 2276 0.0102
548 GOUT 182 0.0101
549 ARTHROPOD BITE 75 0.0101
550 BRONCHITIS 749 0.0101
551 DYSPEPSIA 992 0.0101
552 SKIN ULCER 260 0.0100
553 LOCALISED INFECTION 243 0.0100
554 HYPOCALCAEMIA 190 0.0100
555 CHILLS 1169 0.0100
556 PANCREATITIS 526 0.0099
557 MULTIPLE ALLERGIES 78 0.0099
558 TRICUSPID VALVE INCOMPETENCE 79 0.0099
559 HYPERGLYCAEMIA 362 0.0099
560 INFUSION SITE PAIN 128 0.0099
561 SUPRAVENTRICULAR TACHYCARDIA 95 0.0099
562 URINARY RETENTION 331 0.0099
563 FEEDING DISORDER 201 0.0099
564 ADRENAL INSUFFICIENCY 120 0.0099
565 GLOMERULAR FILTRATION RATE DECREASED 121 0.0098
566 DEFORMITY 92 0.0098
567 DRUG TOXICITY 134 0.0098
568 BASAL CELL CARCINOMA 153 0.0098
569 ATRIAL FIBRILLATION 954 0.0098
570 RASH ERYTHEMATOUS 466 0.0097
571 TACHYCARDIA 862 0.0097
572 HERPES ZOSTER 557 0.0097
573 COELIAC DISEASE 95 0.0097
574 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 465 0.0097
575 LABORATORY TEST ABNORMAL 285 0.0096
576 HICCUPS 79 0.0096
577 VOMITING 4522 0.0096
578 DECREASED APPETITE 2227 0.0096
579 IRON DEFICIENCY ANAEMIA 88 0.0095
580 TASTE DISORDER 193 0.0095
581 COLITIS ULCERATIVE 423 0.0095
582 JOINT STIFFNESS 248 0.0094
583 SMALL INTESTINAL OBSTRUCTION 116 0.0094
584 HYPERTENSION 1985 0.0094
585 HEART RATE DECREASED 329 0.0094
586 HYPOTENSION 1862 0.0093
587 FLUID OVERLOAD 135 0.0093
588 KIDNEY INFECTION 182 0.0093
589 MUSCULAR WEAKNESS 1053 0.0093
590 HAEMATOMA 240 0.0093
591 LIP SWELLING 308 0.0092
592 GASTRITIS 243 0.0092
593 DIALYSIS 131 0.0092
594 HEPATIC ENCEPHALOPATHY 86 0.0092
595 HEPATOTOXICITY 205 0.0092
596 ISCHAEMIC STROKE 164 0.0092
597 TRANSFUSION 96 0.0092
598 DYSPNOEA 5182 0.0091
599 VENTRICULAR EXTRASYSTOLES 95 0.0091
600 DISEASE PROGRESSION 1080 0.0091
601 BLOOD POTASSIUM DECREASED 273 0.0091
602 SLEEP APNOEA SYNDROME 173 0.0091
603 HYPOTHYROIDISM 289 0.0090
604 PROCEDURAL PAIN 251 0.0090
605 DYSPHONIA 529 0.0090
606 BLOOD COUNT ABNORMAL 137 0.0090
607 ILEUS 112 0.0090
608 HOSPICE CARE 89 0.0090
609 DIARRHOEA 5815 0.0090
610 ASTHENIA 3381 0.0090
611 IMMUNODEFICIENCY 134 0.0090
612 PULMONARY HYPERTENSION 187 0.0090
613 HYPOAESTHESIA 1340 0.0089
614 WEIGHT DECREASED 2496 0.0089
615 PRURITUS 3435 0.0089
616 EMPHYSEMA 90 0.0089
617 DISABILITY 176 0.0089
618 EOSINOPHIL COUNT INCREASED 74 0.0089
619 GASTROENTERITIS VIRAL 160 0.0089
620 COMA 421 0.0088
621 FURUNCLE 70 0.0088
622 GALLBLADDER DISORDER 157 0.0088
623 CHEST PAIN 1619 0.0087
624 TENDONITIS 135 0.0087
625 TREATMENT FAILURE 722 0.0087
626 TOOTH FRACTURE 96 0.0087
627 FLUID RETENTION 441 0.0087
628 CYST 107 0.0086
629 EPILEPSY 263 0.0086
630 SINUS BRADYCARDIA 83 0.0086
631 PULMONARY OEDEMA 384 0.0086
632 AMNESIA 557 0.0086
633 RIB FRACTURE 176 0.0085
634 GRAND MAL CONVULSION 79 0.0085
635 SPUTUM DISCOLOURED 81 0.0085
636 PLATELET COUNT INCREASED 111 0.0085
637 TOOTH INFECTION 112 0.0085
638 MYOCARDITIS 97 0.0085
639 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 602 0.0085
640 ASTHMA 952 0.0084
641 CHOLELITHIASIS 275 0.0084
642 ANAL INCONTINENCE 75 0.0083
643 STATUS EPILEPTICUS 94 0.0083
644 CARDIOMYOPATHY 123 0.0083
645 ABDOMINAL PAIN UPPER 1712 0.0083
646 CHOLECYSTITIS 99 0.0083
647 ABSCESS 132 0.0083
648 CONSTIPATION 1796 0.0082
649 FOOT FRACTURE 156 0.0082
650 DENTAL CARIES 91 0.0082
651 TOOTH LOSS 170 0.0082
652 IMMUNE SYSTEM DISORDER 108 0.0082
653 OSTEONECROSIS 269 0.0082
654 SUBARACHNOID HAEMORRHAGE 83 0.0081
655 ARTHRALGIA 3380 0.0081
656 PULMONARY CONGESTION 107 0.0081
657 CONDITION AGGRAVATED 2465 0.0081
658 SINUS CONGESTION 109 0.0081
659 LYMPHOMA 124 0.0080
660 RENAL PAIN 85 0.0080
661 HYPOTHERMIA 81 0.0080
662 MEDICATION ERROR 444 0.0080
663 BONE LOSS 119 0.0079
664 BLOOD URINE PRESENT 150 0.0079
665 PRESYNCOPE 192 0.0079
666 BACK PAIN 1828 0.0079
667 SUDDEN DEATH 83 0.0078
668 FATIGUE 6098 0.0078
669 QUALITY OF LIFE DECREASED 105 0.0078
670 RASH PAPULAR 175 0.0078
671 COUGH 2186 0.0078
672 HALLUCINATION, VISUAL 164 0.0078
673 ALOPECIA 1525 0.0078
674 BRAIN OEDEMA 98 0.0078
675 CARDIAC FAILURE 618 0.0077
676 URINARY INCONTINENCE 228 0.0077
677 ACUTE HEPATIC FAILURE 105 0.0077
678 HAEMATOCHEZIA 423 0.0077
679 NECK PAIN 428 0.0077
680 BLADDER DISORDER 76 0.0076
681 ANXIETY 2175 0.0076
682 THROMBOSIS 614 0.0076
683 RASH MACULAR 265 0.0076
684 DYSPHAGIA 717 0.0075
685 PAIN 4630 0.0075
686 RESTLESS LEGS SYNDROME 137 0.0075
687 INSOMNIA 2006 0.0075
688 CARDIOGENIC SHOCK 108 0.0075
689 PULMONARY THROMBOSIS 82 0.0075
690 NEPHROLITHIASIS 344 0.0075
691 SINUS DISORDER 148 0.0075
692 POOR VENOUS ACCESS 77 0.0074
693 SHOCK 171 0.0074
694 OFF LABEL USE 6509 0.0074
695 SCAR 127 0.0074
696 BLOOD TRIGLYCERIDES INCREASED 131 0.0074
697 LACTIC ACIDOSIS 239 0.0074
698 DISORIENTATION 292 0.0074
699 BRONCHOSPASM 105 0.0074
700 RHABDOMYOLYSIS 306 0.0073
701 CONVULSION 418 0.0073
702 NO THERAPEUTIC RESPONSE 89 0.0073
703 NAUSEA 5766 0.0073
704 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 398 0.0072
705 BONE DISORDER 132 0.0072
706 HYPOGLYCAEMIA 350 0.0072
707 APHASIA 217 0.0072
708 VENTRICULAR TACHYCARDIA 118 0.0071
709 EPISTAXIS 534 0.0071
710 ASPIRATION 78 0.0071
711 RENAL INJURY 211 0.0071
712 MULTIPLE FRACTURES 116 0.0071
713 LETHARGY 406 0.0070
714 ARTHRITIS 554 0.0070
715 FEELING JITTERY 134 0.0070
716 TREMOR 1164 0.0070
717 OROPHARYNGEAL PAIN 649 0.0070
718 DIVERTICULITIS 193 0.0070
719 PARAESTHESIA 1092 0.0069
720 ADVERSE REACTION 92 0.0069
721 POLYNEUROPATHY 83 0.0069
722 ERYTHEMA 1422 0.0069
723 MALAISE 3030 0.0069
724 PALLOR 188 0.0069
725 INCONTINENCE 73 0.0069
726 RENAL DISORDER 321 0.0069
727 TENDON RUPTURE 85 0.0069
728 BLOOD CREATINE PHOSPHOKINASE INCREASED 198 0.0069
729 MYOCARDIAL ISCHAEMIA 78 0.0068
730 BONE PAIN 399 0.0068
731 MUSCLE SPASMS 1249 0.0068
732 DYSARTHRIA 256 0.0068
733 JOINT INJURY 145 0.0068
734 DEAFNESS 177 0.0068
735 INFLUENZA 753 0.0067
736 RESPIRATORY TRACT CONGESTION 107 0.0067
737 HEMIPARESIS 114 0.0067
738 DIABETES MELLITUS INADEQUATE CONTROL 119 0.0067
739 BRADYCARDIA 355 0.0067
740 MUSCLE TWITCHING 154 0.0067
741 MIGRAINE 636 0.0067
742 UPPER GASTROINTESTINAL HAEMORRHAGE 112 0.0067
743 HEPATIC FUNCTION ABNORMAL 248 0.0066
744 MELAENA 146 0.0066
745 POLLAKIURIA 276 0.0066
746 CHROMATURIA 149 0.0066
747 CARDIO-RESPIRATORY ARREST 276 0.0066
748 SUBDURAL HAEMATOMA 94 0.0066
749 UNRESPONSIVE TO STIMULI 169 0.0065
750 EATING DISORDER 139 0.0065
751 PULMONARY ARTERIAL HYPERTENSION 94 0.0065
752 HEADACHE 4065 0.0065
753 ANAPHYLACTIC REACTION 358 0.0065
754 MUSCLE ATROPHY 82 0.0065
755 NOCTURIA 78 0.0064
756 COVID-19 1127 0.0064
757 CIRCULATORY COLLAPSE 109 0.0064
758 HEART RATE INCREASED 634 0.0064
759 SECRETION DISCHARGE 80 0.0064
760 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 333 0.0064
761 ABDOMINAL PAIN LOWER 161 0.0064
762 NASAL CONGESTION 371 0.0063
763 CARDIAC ARREST 521 0.0063
764 ORAL HERPES 123 0.0063
765 GASTROINTESTINAL HAEMORRHAGE 526 0.0063
766 DISEASE RECURRENCE 299 0.0063
767 GASTRIC ULCER 119 0.0063
768 DERMATITIS 131 0.0062
769 ROTATOR CUFF SYNDROME 80 0.0062
770 CARPAL TUNNEL SYNDROME 87 0.0062
771 DRY EYE 310 0.0062
772 SKIN REACTION 87 0.0062
773 PRODUCT USE IN UNAPPROVED INDICATION 1530 0.0062
774 DEPRESSION 1404 0.0062
775 IMPAIRED GASTRIC EMPTYING 84 0.0062
776 PAIN IN JAW 174 0.0061
777 PAIN IN EXTREMITY 1805 0.0061
778 HALLUCINATION 461 0.0061
779 ELECTROCARDIOGRAM QT PROLONGED 220 0.0061
780 ABDOMINAL DISTENSION 635 0.0061
781 INSURANCE ISSUE 93 0.0061
782 EYELID OEDEMA 70 0.0060
783 EMOTIONAL DISTRESS 729 0.0060
784 MYALGIA 1018 0.0060
785 HEART RATE IRREGULAR 134 0.0059
786 LIMB INJURY 161 0.0059
787 CYANOSIS 93 0.0059
788 ANKLE FRACTURE 91 0.0059
789 GAIT DISTURBANCE 1122 0.0059
790 AGEUSIA 146 0.0058
791 SKIN DISCOLOURATION 268 0.0058
792 INTERVERTEBRAL DISC PROTRUSION 127 0.0058
793 BLOOD PRESSURE DECREASED 383 0.0058
794 IMPAIRED WORK ABILITY 122 0.0057
795 VERTIGO 346 0.0057
796 FEELING HOT 347 0.0057
797 PRURITUS GENERALISED 122 0.0056
798 NERVOUS SYSTEM DISORDER 176 0.0056
799 MEMORY IMPAIRMENT 773 0.0056
800 CHEST DISCOMFORT 576 0.0056
801 MIDDLE INSOMNIA 105 0.0056
802 SNEEZING 126 0.0056
803 SYNCOPE 561 0.0056
804 SKIN EXFOLIATION 473 0.0056
805 HAEMATEMESIS 142 0.0056
806 DIABETES MELLITUS 427 0.0056
807 PHARYNGEAL OEDEMA 86 0.0056
808 MASS 78 0.0056
809 DIZZINESS 2779 0.0056
810 MUSCULOSKELETAL DISORDER 106 0.0056
811 GINGIVAL BLEEDING 76 0.0056
812 CEREBRAL HAEMORRHAGE 199 0.0056
813 HAEMORRHAGE INTRACRANIAL 83 0.0055
814 ARRHYTHMIA 262 0.0055
815 CORONARY ARTERY DISEASE 167 0.0055
816 RHINORRHOEA 356 0.0055
817 ADVERSE DRUG REACTION 494 0.0055
818 SPINAL FRACTURE 110 0.0055
819 TINNITUS 252 0.0055
820 BLOOD TEST ABNORMAL 77 0.0055
821 POST PROCEDURAL COMPLICATION 105 0.0055
822 PERIPHERAL COLDNESS 75 0.0055
823 TOOTH DISORDER 121 0.0054
824 FALL 1803 0.0054
825 BLOOD PRESSURE ABNORMAL 107 0.0054
826 PRODUCT USE ISSUE 1010 0.0054
827 CARDIAC FAILURE CONGESTIVE 431 0.0054
828 BALANCE DISORDER 463 0.0054
829 FEELING COLD 149 0.0053
830 NEOPLASM PROGRESSION 186 0.0053
831 SKIN DISORDER 178 0.0053
832 PERITONITIS 110 0.0053
833 SKIN CANCER 114 0.0053
834 ACUTE MYOCARDIAL INFARCTION 156 0.0053
835 EYE PAIN 294 0.0052
836 SPEECH DISORDER 273 0.0052
837 POOR QUALITY SLEEP 112 0.0052
838 SOMNOLENCE 1046 0.0052
839 BLOOD PRESSURE INCREASED 793 0.0052
840 COGNITIVE DISORDER 241 0.0052
841 LOCAL SWELLING 90 0.0052
842 THROAT TIGHTNESS 139 0.0051
843 RETCHING 109 0.0051
844 INTESTINAL OBSTRUCTION 192 0.0051
845 AGITATION 374 0.0051
846 DIPLOPIA 132 0.0051
847 PALPITATIONS 593 0.0051
848 GENERALISED TONIC-CLONIC SEIZURE 83 0.0050
849 ACTIVITIES OF DAILY LIVING IMPAIRED 99 0.0050
850 EXPOSURE DURING PREGNANCY 310 0.0050
851 CATARACT 297 0.0050
852 TRANSIENT ISCHAEMIC ATTACK 167 0.0049
853 FAECES DISCOLOURED 107 0.0049
854 SEIZURE 566 0.0049
855 LOSS OF CONSCIOUSNESS 623 0.0049
856 HERNIA 94 0.0049
857 TOOTHACHE 87 0.0048
858 DYSSTASIA 140 0.0048
859 HIP FRACTURE 154 0.0048
860 DYSKINESIA 193 0.0047
861 UPPER LIMB FRACTURE 94 0.0047
862 HYPERSOMNIA 135 0.0047
863 ALTERED STATE OF CONSCIOUSNESS 102 0.0047
864 OCULAR HYPERAEMIA 223 0.0047
865 THERAPY PARTIAL RESPONDER 73 0.0047
866 TREATMENT NONCOMPLIANCE 256 0.0047
867 HALLUCINATION, AUDITORY 74 0.0047
868 MUSCLE TIGHTNESS 73 0.0045
869 HOSPITALISATION 692 0.0045
870 BURNING SENSATION 314 0.0045
871 ADVERSE EVENT 411 0.0045
872 SENSORY DISTURBANCE 71 0.0044
873 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 103 0.0044
874 VISION BLURRED 604 0.0044
875 ECZEMA 230 0.0044
876 HEAD INJURY 138 0.0044
877 HYPERHIDROSIS 561 0.0044
878 MUSCULOSKELETAL DISCOMFORT 74 0.0043
879 ILLNESS 441 0.0043
880 THROAT IRRITATION 192 0.0043
881 METASTASES TO LIVER 75 0.0043
882 DEMENTIA 119 0.0043
883 DEPRESSED LEVEL OF CONSCIOUSNESS 168 0.0042
884 VISUAL ACUITY REDUCED 141 0.0042
885 THINKING ABNORMAL 79 0.0042
886 MALIGNANT NEOPLASM PROGRESSION 432 0.0042
887 OSTEONECROSIS OF JAW 104 0.0042
888 THIRST 75 0.0042
889 FLATULENCE 238 0.0042
890 INFLUENZA LIKE ILLNESS 345 0.0042
891 VISUAL IMPAIRMENT 517 0.0042
892 EYE SWELLING 154 0.0041
893 MENTAL DISORDER 180 0.0041
894 FEAR 111 0.0041
895 FRACTURE 78 0.0041
896 PRODUCT ADMINISTRATION ERROR 82 0.0041
897 CEREBRAL INFARCTION 99 0.0040
898 LACRIMATION INCREASED 122 0.0040
899 UNEVALUABLE EVENT 304 0.0040
900 NIGHTMARE 138 0.0040
901 FEMUR FRACTURE 122 0.0039
902 EYE DISORDER 129 0.0039
903 LIMB DISCOMFORT 121 0.0039
904 DRUG EXPOSURE DURING PREGNANCY 133 0.0039
905 ACCIDENTAL OVERDOSE 143 0.0039
906 HAEMORRHAGE 408 0.0039
907 DISTURBANCE IN ATTENTION 210 0.0039
908 ANGINA PECTORIS 111 0.0039
909 GLAUCOMA 73 0.0038
910 RESPIRATORY ARREST 104 0.0038
911 ABASIA 93 0.0038
912 PANIC ATTACK 137 0.0038
913 DYSTONIA 72 0.0037
914 THERAPEUTIC RESPONSE DECREASED 221 0.0036
915 HYPOACUSIS 156 0.0036
916 PREMATURE BABY 109 0.0036
917 DYSGEUSIA 269 0.0036
918 GASTRIC DISORDER 123 0.0036
919 HOT FLUSH 269 0.0036
920 EXTRAPYRAMIDAL DISORDER 88 0.0035
921 MOVEMENT DISORDER 112 0.0035
922 CARDIAC DISORDER 325 0.0035
923 MENTAL IMPAIRMENT 84 0.0035
924 DEPRESSED MOOD 183 0.0035
925 FEELING ABNORMAL 829 0.0035
926 INTENTIONAL DOSE OMISSION 98 0.0034
927 FLUSHING 346 0.0034
928 PRODUCT PRESCRIBING ERROR 81 0.0034
929 DIABETIC KETOACIDOSIS 81 0.0034
930 NEOPLASM MALIGNANT 223 0.0033
931 PRODUCT AVAILABILITY ISSUE 76 0.0033
932 DRUG INEFFECTIVE 4395 0.0033
933 NERVOUSNESS 174 0.0033
934 ANAPHYLACTIC SHOCK 85 0.0033
935 SURGERY 193 0.0033
936 PRODUCT DOSE OMISSION ISSUE 957 0.0033
937 RESTLESSNESS 116 0.0032
938 PAIN OF SKIN 84 0.0031
939 BLINDNESS 126 0.0031
940 EMOTIONAL DISORDER 95 0.0031
941 ABNORMAL BEHAVIOUR 122 0.0031
942 DEATH 2647 0.0031
943 UNDERDOSE 221 0.0030
944 DRY SKIN 403 0.0030
945 FOETAL EXPOSURE DURING PREGNANCY 240 0.0029
946 THERAPY CESSATION 151 0.0029
947 PRODUCT DOSE OMISSION 192 0.0029
948 AGGRESSION 147 0.0029
949 PSYCHOTIC DISORDER 86 0.0029
950 TARDIVE DYSKINESIA 81 0.0029
951 MOOD ALTERED 78 0.0029
952 MYELOSUPPRESSION 103 0.0029
953 IRRITABILITY 170 0.0028
954 BLOOD GLUCOSE DECREASED 135 0.0028
955 ABORTION SPONTANEOUS 111 0.0028
956 CEREBROVASCULAR ACCIDENT 469 0.0028
957 MYOCARDIAL INFARCTION 480 0.0027
958 PRODUCT DOSE OMISSION IN ERROR 76 0.0027
959 THERAPY INTERRUPTED 191 0.0027
960 BLOOD GLUCOSE INCREASED 501 0.0027
961 CRYING 96 0.0026
962 TOXICITY TO VARIOUS AGENTS 443 0.0026
963 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 468 0.0026
964 EYE IRRITATION 144 0.0025
965 LUNG NEOPLASM MALIGNANT 100 0.0024
966 THERAPEUTIC RESPONSE UNEXPECTED 107 0.0024
967 MOOD SWINGS 76 0.0024
968 INJECTION SITE REACTION 159 0.0023
969 PSORIASIS 299 0.0023
970 SUICIDAL IDEATION 203 0.0022
971 OVERDOSE 473 0.0022
972 EYE PRURITUS 73 0.0022
973 MULTIPLE SCLEROSIS 98 0.0020
974 VAGINAL HAEMORRHAGE 85 0.0020
975 ACNE 148 0.0020
976 DRUG DOSE OMISSION 293 0.0018
977 INTENTIONAL PRODUCT MISUSE 152 0.0017
978 MULTIPLE SCLEROSIS RELAPSE 117 0.0017
979 INCORRECT DOSE ADMINISTERED 376 0.0016
980 SKIN BURNING SENSATION 113 0.0016
981 SUICIDE ATTEMPT 91 0.0015
982 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 105 0.0015
983 PROSTATE CANCER 113 0.0014
984 PRODUCT QUALITY ISSUE 168 0.0012
985 NO ADVERSE EVENT 200 0.0011
986 INJECTION SITE SWELLING 84 0.0011
987 INJECTION SITE ERYTHEMA 135 0.0011
988 DEVICE ISSUE 94 0.0010
989 INJECTION SITE BRUISING 82 0.0010
990 DRUG ABUSE 79 0.0009
991 INJECTION SITE PAIN 275 0.0009
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 166 0.0008
993 BREAST CANCER 72 0.0008
994 DRUG DEPENDENCE 79 0.0005